EYEGENE INC

Patent Applications and Registrations

Patent applications and USPTO patent grants for EYEGENE INC.The latest application filed is for "composition for inhibiting saponin-induced hemolysis, containing cationic liposome".

Company Profile

9.15.14

EYEGENE INC - Seoul KR
EYEGENE INC. - Seoul KR
Eyegene Inc. -
EYEGENE, INC. - 187-114, YONHEE 3-DONG, SEWDAEMOON-GU SEOUL, KOREA, REPUBLIC OF 120-113 KR
EyeGene Inc. - 187-114, Yonhee-3-dong Seodaemun-gu, Seoul, 120-113 KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Composition For Inhibiting Saponin-induced Hemolysis, Containing Cationic Liposome App 20220287970 - CHO; Yang Je ; et al.	2022-09-15
Pharmaceutical Composition For Preventing Or Treating Inflammatory Diseases App 20210353711 - CHO; Yang Je ; et al.	2021-11-18
Immune modulator and vaccine composition containing the same Grant 10,918,709 - Cho , et al. February 16, 2	2021-02-16
Composition for enhancing immunity comprising immune modulator and cationic liposome, and use of same Grant 10,874,733 - Cho , et al. December 29, 2	2020-12-29
Method for treating vascular-related disease Grant RE48,023 - Kim , et al.	2020-06-02
Immune Modulator And Vaccine Composition Containing The Same App 20190290749 - Cho; Yang Je ; et al.	2019-09-26
Composition For Enhancing Immunity Comprising Immune Modulator And Cationic Liposome, And Use Of Same App 20190255171 - Cho; Yang Je ; et al.	2019-08-22
Vaccine for inducing an improved immune reaction Grant 9,572,877 - Cho , et al. February 21, 2	2017-02-21
Vaccine for cervical cancer Grant 9,566,323 - Kim , et al. February 14, 2	2017-02-14
Pharmaceutical composition for preventing or treating arteriosclerosis Grant 9,290,542 - Cho , et al. March 22, 2	2016-03-22
Method for treating vascular-related disease Grant 9,101,581 - Kim , et al. August 11, 2	2015-08-11
Pharmaceutical Composition For Preventing Or Treating Arteriosclerosis App 20150038405 - Cho; Yang Je ; et al.	2015-02-05
Immune stimulating composition comprising bacterial chromosomal DNA fragments having methylated CpG sequences and non-toxic lipopolysaccharides Grant 8,883,987 - Ahn , et al. November 11, 2	2014-11-11
Method For Treating Vascular-related Disease App 20140105868 - KIM; Doo-Sik ; et al.	2014-04-17
Vaccine For Inducing An Improved Immune Reaction App 20130273101 - Cho; Yang Je ; et al.	2013-10-17
Composition for treating retinopathy or glaucoma comprising thrombin derived peptides Grant 8,372,811 - Jang , et al. February 12, 2	2013-02-12
Vaccine for Cervical Cancer App 20120100169 - Kim; Hong-Jin ; et al.	2012-04-26
Composition for Treating Retinopathy or Glaucoma Comprising Thrombin Derived Peptides App 20100297100 - Jang; Jin-Wook ; et al.	2010-11-25
Method for Diagnosing Diabetic Retinopathy by Single Nucleotide Polymorphism, DNA Fragment Thereof, and Primer Thereof App 20090286233 - Cho; Yang-Je ; et al.	2009-11-19
Immune stimulating and controlling composition comprising bacterial chromosomal DNA fragments and non-toxic lipopolysaccharides Grant 7,507,802 - Ahn , et al. March 24, 2	2009-03-24
Composition For Analyzing Diabetes Mellitus And/or Retinal Vascular Disease And Analyzing Method Thereof App 20090061465 - Cho; Yang-Je ; et al.	2009-03-05
Polypeptide Inducing the Secretion of Angiopoietin App 20080009441 - Cho; Yang-Je ; et al.	2008-01-10
Immune stimulating and controlling composition comprising bacterial chromosomal dna fragments and non-toxic lipopolysaccharides App 20050163806 - Ahn, Bo Young ; et al.	2005-07-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.